InChI=1S/C28H50NO7P/c1- 5- 6- 7- 8- 9- 10- 11- 12- 13- 14- 15- 16- 17- 18- 19- 20- 21- 22- 28(31) 36- 27(25- 30) 26- 35- 37(32,33) 34- 24- 23- 29(2,3) 4/h9- 10,12- 13,15- 16,18- 19,27,30H,5- 8,11,14,17,20- 26H2,1- 4H3/b10- 9- ,13- 12- ,16- 15- ,19- 18- /t27- /m1/s1 |
IGJKYDBBINVMLH-JXRLJXCWSA-N |
CCCCC\C=C/C\C=C/C\C=C/C\C=C/CCCC(=O)O[C@H](CO)COP([O-])(=O)OCC[N+](C)(C)C |
|
human metabolite
Any mammalian metabolite produced during a metabolic reaction in humans (Homo sapiens).
(via lysophosphatidylcholine(0:0/20:4) )
(via lysophosphatidylcholine )
|
|
(2R)- 3- hydroxy- 2- [(5Z,8Z,11Z,14Z)- icosa- 5,8,11,14- tetraenoyloxy]propyl 2- (trimethylazaniumyl)ethyl phosphate
|
2-(5Z,8Z,11Z,14Z)-eicosatetraenoyl-sn-glycero-3-phosphocholine
|
UniProt
|
2-(5Z,8Z,11Z,14Z)-icosatetraenoyl-sn-glycero-3-phosphocholine
|
SUBMITTER
|
2-arachidonoyl-GPC
|
ChEBI
|
2-arachidonoyllysophosphatidylcholine
|
SUBMITTER
|
GPC(0:0/20:4)
|
ChEBI
|
GPC(20:4)
|
ChEBI
|
LPC(0:0/20:4(5Z,8Z,11Z,14Z))
|
LIPID MAPS
|
PC(0:0/20:4(5Z,8Z,11Z,14Z))
|
LIPID MAPS
|